Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big Pharma's Uphill 2013 Battle
Motley Fool
Wednesday, February 6, 2013 - 11:02am
tags:
Big Pharma, Merck, Pfizer, JNJ, Bristol-Myers Squibb, Novartis
Avanir Pharmaceuticals Earnings: An Early Look
Motley Fool
Wednesday, February 6, 2013 - 11:01am
tags:
Avanir, earnings
How Big Pharma Gets Bigger, And What Little Pharma Can Do About It
Seeking Alpha
Wednesday, February 6, 2013 - 10:12am
tags:
Big Pharma, Novartis, NovaBay Pharmaceuticals, Sanofi, Roche
PhRMA Is Not Effective in Improving the Image of the Pharma Industry
Forbes
Wednesday, February 6, 2013 - 10:09am
tags:
PhRMA
EnteroMedics: Fat Zapper or Pulsing Placebo?
TheStreet.com
Wednesday, February 6, 2013 - 8:37am
tags:
EnteroMedics, Vivus, Arena Pharmaceuticals, Vbloc
GlaxoSmithKline expanding restructuring program
The Fly on the Wall
Wednesday, February 6, 2013 - 8:35am
tags:
GSK, restructuring
What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool
Wednesday, February 6, 2013 - 8:34am
tags:
diabetes, Merck, SGLT2 inhibitor, Bristol-Myers Squibb, AstraZeneca, JNJ, Array Biopharma, Januvia, Amgen, Forixga, GKAs
Biogen pays Elan $3.25 billion to take over MS drug
Reuters
Wednesday, February 6, 2013 - 8:25am
tags:
Biogen Idec, Elan, Tysabri, M&A, MS, multiple sclerosis
Med-tech trends: The most talked about device makers in January 2013
Mass Device
Tuesday, February 5, 2013 - 11:11pm
tags:
med-tech, devices
Boston Scientific laid off another 500 workers last summer, records show
Mass Device
Tuesday, February 5, 2013 - 11:10pm
tags:
Boston Scientific, layoffs, Management, devices
Urologix names new CEO | Personnel Moves
Mass Device
Tuesday, February 5, 2013 - 11:10pm
tags:
Urologix, CEO, Management, devices
Diabetes: GI Dynamics touts positive results in "mildly obese" patients treated with EndoBarrier
Mass Device
Tuesday, February 5, 2013 - 11:09pm
tags:
diabetes, GI Dynamics, patients, EndoBarrier
GE Healthcare and NFL team up to fight sports-related brain injuries
Mass Device
Tuesday, February 5, 2013 - 11:09pm
tags:
GE Healthcare, sports, brain, injuries, devices
House majority leader Eric Cantor decries the medical device tax
Mass Device
Tuesday, February 5, 2013 - 11:08pm
tags:
congress, device tax, devices
Techne Corporation Releases Unaudited Second Quarter And Six Month Fiscal Year 2013 Results
Yahoo/PRNewswire
Tuesday, February 5, 2013 - 10:29pm
tags:
Techne, earnings, devices
Symmetry Medical to Report Fourth Quarter and Full Year 2012 Financial Results on February 21, 2013
Yahoo/GlobeNewswire
Tuesday, February 5, 2013 - 10:29pm
tags:
Symmetry Medical, earnings, devices
BSD Medical Reports Publication of Clinical Study Results of Hyperthermia Using the BSD-2000 and Chemotherapy to Treat Advanced Pancreatic Cancer Patients
Yahoo/BusinessWire
Tuesday, February 5, 2013 - 10:27pm
tags:
BSD Medical, Clinical Research, devices, Hyperthermia, cancer, treatment
Minnesota Timberwolves Star Ricky Rubio Teams Up with Medtronic Foundation to Save Young Lives from Sudden Cardiac Arrest
Yahoo/Reuters
Tuesday, February 5, 2013 - 10:23pm
tags:
Medtronic, Cardiac, devices
Uroplasty Announces Executive Changes In US Sales Organization
Yahoo/PRNewswire
Tuesday, February 5, 2013 - 10:22pm
tags:
Uroplasty, Management, devices
Zimmer Told to Pay Stryker $70 Million for Surgical Tool Patents
Bloomberg
Tuesday, February 5, 2013 - 10:22pm
tags:
Zimmer, Stryker, patent, surgical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.